Valuation: Simcere Pharmaceutical Group Limited

Market Cap 3.96B 31.02B 3.39B 3.17B 2.9B 5.45B 379B 5.52B 37.47B 14.61B 190B 14.86B 14.54B 629B P/E 2026 *
15.6x
P/E 2027 * 13.5x
Enterprise Value 3.77B 29.56B 3.23B 3.02B 2.77B 5.19B 361B 5.26B 35.7B 13.92B 181B 14.16B 13.85B 599B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.27x
Free-Float
32.48%
Yield 2026 *
3.42%
Yield 2027 * 3.93%
1 day-0.98%
1 week-0.74%
Current month-2.19%
1 month-7.22%
3 months+15.60%
6 months-4.88%
Current year+0.92%
1 week 11.87
Extreme 11.87
12.82
1 month 11.63
Extreme 11.63
13.52
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
15.08
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 20/08/2026
Director of Finance/CFO 55 19/11/2019
Chief Executive Officer 54 25/03/2026
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap.
13/7/26 Other

Founder

-47,000 0.0018%
13/7/26 Other

Director

-47,000 0.0018%
10/7/26 Other

Founder

-53,000 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%-0.74%-2.42%+90.24% 4B
-0.08%-1.53%+16.49%+67.63% 47.74B
-3.21%-1.93%+51.06%+125.79% 41.7B
-0.40%-1.82%-7.37%+15.84% 12.14B
+1.11%-4.05%+13.90%+72.88% 11.55B
0.00%0.00%+30.00%+147.62% 9.18B
-0.39%+0.62%+19.93%+39.54% 7.54B
-1.35%+1.26%+44.30%-11.69% 7.35B
-0.64%-0.09%+20.47%+202.52% 6.88B
-5.36%-8.72%-34.95%+17.39% 5.72B
Average -1.13%-1.13%+15.14%+76.78% 15.38B
Weighted average by Cap. -1.18%-0.74%+23.86%+84.06%

Financials

2026 *2027 *
Net sales 1.5B 11.75B 1.28B 1.2B 1.1B 2.06B 143B 2.09B 14.2B 5.54B 72.06B 5.63B 5.51B 238B 1.69B 13.27B 1.45B 1.36B 1.24B 2.33B 162B 2.36B 16.03B 6.25B 81.36B 6.36B 6.22B 269B
Net income 246M 1.93B 211M 197M 181M 339M 23.55B 343M 2.33B 909M 11.83B 924M 904M 39.12B 292M 2.29B 250M 234M 215M 403M 27.98B 408M 2.77B 1.08B 14.05B 1.1B 1.07B 46.49B
Net Debt -187M -1.47B -160M -150M -137M -257M -17.88B -261M -1.77B -690M -8.98B -702M -686M -29.71B -123M -961M -105M -98.24M -89.93M -169M -11.73B -171M -1.16B -453M -5.89B -460M -450M -19.49B
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
7,038
Date Price Change Volume
21/08/26 HKD 12.08 -0.98% 7,444,000
20/08/26 HKD 12.20 +0.25% 14,074,000
19/08/26 HKD 12.17 -2.41% 4,967,000
18/08/26 HKD 12.47 +0.81% 4,099,000
17/08/26 HKD 12.37 +1.89% 6,206,126
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
10.36CNY
Average target price
15.29CNY
Spread / Average Target
+47.55%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2096 Stock